Beam Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BEAM research report →
About the company
Beam Therapeutics Inc. , founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States.
- CEO
- John Evans
- IPO
- 2020
- Employees
- 393
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $2.99B
- P/E
- -46.09
- P/S
- 18.21
- P/B
- 2.57
- EV/EBITDA
- -92.08
- Div Yield
- 0.00%
- Gross Margin
- -32.43%
- Op Margin
- -226.58%
- Net Margin
- -39.66%
- ROE
- -5.89%
- ROIC
- -26.15%
- Revenue
- $139.74M · 120.01%
- Net Income
- $-79,992,000 · 78.77%
- EPS
- $-0.81 · 82.31%
- Op Income
- $-383,693,000
- FCF YoY
- -1.08%
- 52W High
- $36.44
- 52W Low
- $15.60
- 50D MA
- $29.56
- 200D MA
- $26.68
- Beta
- 2.20
- Avg Volume
- 2.08M
Get TickerSpark's AI analysis on BEAM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | Shaw Christi | other | 19,676 |
| Jun 3, 26 | Walsh Kathleen E | other | 19,676 |
| Jun 3, 26 | MARAGANORE JOHN | other | 19,676 |
| Jun 3, 26 | Fishman Mark | other | 19,676 |
| Jun 3, 26 | Guindo Chirfi | other | 19,676 |
| Jun 3, 26 | COOPER GRAHAM K | other | 19,676 |
| Apr 1, 26 | Evans John M. | sell | 30,078 |
| Apr 1, 26 | Simon Amy | sell | 6,700 |
| Apr 1, 26 | Cavanagh Bethany J | sell | 3,242 |
| Apr 1, 26 | Bellon Christine | sell | 5,956 |
Our BEAM coverage
Recent articles, reports, and earnings notes.
Want a deeper read on BEAM?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.